The implementation of CTIS is a crucial step towards a more efficient and competitive clinical research ecosystem in Europe, benefiting both researchers and patients
Read moreLa colaboración del Complejo Asistencial Universitario de Salamanca a través del IBSAL y del Hospital Virgen de Rocío, mediante el Instituto de Biomedicina de Sevilla, ha logrado la financiación d...
Read moreHospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulatory authority (AEMPS).
Read moreQuiere comprobar que la tensión disminuye con una terapia, alternativa a la medicación, que modula los intervalos cardíacos programados por los marcapasos
Read moreThe round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial
Read moreAnaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, today announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical ...
Read moreEl fin último es poder tratar con esa piel bioimpresa a pacientes infantiles con grandes quemaduras, ya que con el uso de piel autóloga (del propio paciente) se evita el rechazo que se produce cuand...
Read moreThe funding will drive two preclinical development programs for its groundbreaking drug, ACT-02—an innovative compound with potential disease-modifying properties. ACT-02 functions as an inhibitor o...
Read moreMás de 500 pacientes ya se han beneficiado de la estimulación cerebral profunda que, junto al HIFU y la radiación Gammaknife, constituyen las técnicas más innovadoras en los casos más complejos ...
Read moreNowadays, technology provides us with excellent tools to optimize the patient recruitment process for clinical trials, improving efficiency and expanding the reach of information among suitable partic...
Read moreOryzon Genomics announced today that the first patient has been dosed in a Phase I/II trial of iadademstat, Oryzon’s potent and selective LSD1 inhibitor, in combination with immune checkpoint inhibi...
Read more¿Qué pasa si no se ha completado la transición de tu ensayo clínico al Reglamento (UE) 536/2014 y, por tanto, al CTIS? El reglamento contempla una serie de acciones y medidas correctivas para esto...
Read more